Deadline: 15-Sep-21
The European Commission’s Action grants on substances of human origin (SoHo) – Increase resilience, ensure continuity of supply and access to safe and high quality therapies, in particular in times of crisis.
This action aims to enable the medical/professional organisations and Member State authorities in SoHO subsectors to develop and exchange good practices for professionals and authorities to optimise supply and increase access to quality and safe use of critical therapies based on substances of human origin donated by fellow citizens.
Activities
Proposed measures and actions can be targeted at local/hospital level, regional/national level and supra-national/Union level. The measures and actions developed can be implemented by professionals, in collaboration with their national authorities as appropriate, across the Union.
The work will aim to identify, share, assess and refine measures and actions taken and planned to mitigate the impact of the COVID-19 pandemic on safety, quality and accessibility of these therapies.
- The specific sub-sectors that will be supported include in particular:
- blood and blood components (red blood cells, plasma);
- organs (e.g. kidneys, liver, heart);
- haematopoietic stem cells (bone marrow, cord blood);
- gametes and embryos (for reproductive medicine);
- tissues (corneas, heart valves).
Funding Information
- The available budget for this call is EUR 3 500 000.
Expected Results
The expected results of this action are the following:
- Development and dissemination of good practices and guidance by medical/professional associations and Member States authorities in the SoHO subsectors to strengthen and make more resilient transplant, transfusion and medically assisted reproduction systems, in particular during crises;
- Contribution to a more sustainable supply and increased access to essential SoHO therapies with mitigating actions to avoid disruptions (by comparison with the annual volumes monitored routinely for several SoHO subsectors).
- be legal entities (public or private bodies) created under Union law or an international organisation, or
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories linked to it (OCTs)
- eligible non-EU countries:
- EEA countries and countries associated to the EU4Health Programme (third countries, candidate countries and potential candidate countries, neighbourhood countries) or countries that are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature.
For more information, visit https://bit.ly/3irfxIE
